Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
| Lifeward Ltd.LFWD · Entity 7620 | Director · Chief Executive Officer | May 21, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.6103 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.5195 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.1836 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.486 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Lifeward Ltd.
Report date May 21, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | IndirectESOP | 98,728 |
Reported balance
After 2025-05-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-05-21 · Sale · Disposed 1,909 · Balance 98,728 F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person. |
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | Direct | 2,142 |
Reported balance
Holding disclosure · report date 2025-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,142 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 8, 2026 20:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6637 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385318 · ownership.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.2988 Underlying: Common Stock · 1.6637 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0022 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385318 · ownership.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.486 Underlying: Common Stock · 1.0022 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8852 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385318 · ownership.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1836 Underlying: Common Stock · 0.8852 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6503 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385318 · ownership.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.5195 Underlying: Common Stock · 0.6503 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.5429 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385318 · ownership.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.6103 Underlying: Common Stock · 0.5429 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:38 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4274 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260031 · ownership.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.6351 Underlying: Common Stock · 1.4274 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:38 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8599 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260031 · ownership.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.4838 Underlying: Common Stock · 0.8599 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:38 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7595 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260031 · ownership.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.2984 Underlying: Common Stock · 0.7595 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:38 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.5579 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260031 · ownership.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.8692 Underlying: Common Stock · 0.5579 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:38 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.4658 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260031 · ownership.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0674 Underlying: Common Stock · 0.4658 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 865 | $0.00 Strike: $101.12 | $0.00 |
DisclosureSEC source: 0001193125-26-217096 · ownership.xml · derivative · entry 7 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,729 Underlying: Common Stock · 865 shares Expires 2029-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33.3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 924 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001193125-26-217096 · ownership.xml · derivative · entry 6 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,848 Underlying: Common Stock · 924 shares Expires 2028-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33.3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,069 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0001193125-26-217096 · ownership.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,140 Underlying: Common Stock · 1,069 shares Expires 2027-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 3,943 | $110.00 | $433,730.00 |
DisclosureSEC source: 0001193125-26-217096 · ownership.xml · nonDerivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,714 Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 865 | $101.12 | $87,468.80 |
DisclosureSEC source: 0001193125-26-217096 · ownership.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 924 | $54.65 | $50,496.60 |
DisclosureSEC source: 0001193125-26-217096 · ownership.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,069 | $47.19 | $50,446.11 |
DisclosureSEC source: 0001193125-26-217096 · ownership.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2077 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132236 · ownership.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.2077 Underlying: Common Stock · 1.2077 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7276 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132236 · ownership.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.6239 Underlying: Common Stock · 0.7276 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6426 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132236 · ownership.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.5389 Underlying: Common Stock · 0.6426 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.472 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132236 · ownership.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.3113 Underlying: Common Stock · 0.472 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.3941 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132236 · ownership.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6016 Underlying: Common Stock · 0.3941 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086299 · ownership.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.8963 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086299 · ownership.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F2 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 476 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086299 · ownership.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,798 F1 · shares: These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 1/3 upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next two years. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319537 · ownership.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · balance_after: Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319537 · ownership.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · balance_after: Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319537 · ownership.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319537 · ownership.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 3,431 | $0.00 Strike: $83.66 | $0.00 |
DisclosureSEC source: 0001193125-25-316346 · ownership.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,431 Underlying: Common Stock · 3,431 shares Expires 2030-12-10 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316346 · ownership.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,312 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314622 · ownership.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.8393 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314622 · ownership.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.2075 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314622 · ownership.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314622 · ownership.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 06, 2025 Filed Dec 9, 2025 01:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311607 · ownership.xml · derivative · entry 7 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.8963 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 06, 2025 Filed Dec 9, 2025 01:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311607 · ownership.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9869 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311607 · ownership.xml · derivative · entry 6 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.8963 Underlying: Common Stock · 0.9869 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9702 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311607 · ownership.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.8393 Underlying: Common Stock · 0.9702 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.81 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311607 · ownership.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.2075 Underlying: Common Stock · 0.81 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.4736 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311607 · ownership.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0005 Underlying: Common Stock · 0.4736 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.4736 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311607 · ownership.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.9892 Underlying: Common Stock · 0.4736 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:24 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8697 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028584 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.9094 Underlying: Common Stock · 0.8697 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:24 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8546 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028584 · rdgdoc.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.8691 Underlying: Common Stock · 0.8546 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:24 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7138 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028584 · rdgdoc.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.3975 Underlying: Common Stock · 0.7138 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:24 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.4173 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028584 · rdgdoc.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.5269 Underlying: Common Stock · 0.4173 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 22:24 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.4173 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028584 · rdgdoc.xml · derivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.5156 Underlying: Common Stock · 0.4173 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 976 | $92.78 | $90,553.28 |
DisclosureSEC source: 0001437749-25-026964 · rdgdoc.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,773 Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0387 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0397 Underlying: Common Stock · 1.0387 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0208 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0145 Underlying: Common Stock · 1.0208 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.